CXCL12 and lung carcinoma: Novel therapeutic strategies for targeting TAMs in lung cancer include inhibiting of macrophage recruitment with drugs such as CSF1R antibody (158) and C-X-C motif chemokine ligand 12 (CXCL12) inhibitors.